TORRANCE, Calif. and IRVINE, Calif., Sept. 27, 2012 /PRNewswire/ -- Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, and ChromaDex ® Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today a collaboration agreement that will provide solutions to customers with a combination of reference standards, scientifically valid methods and application support. The collaboration combines Phenomenex's strengths in analytical HPLC (high-performance liquid chromatography) with ChromaDex's extensive line of reference standards, which are used for quality control in dietary supplement manufacturing. The first three new solutions will be presented as scientific posters at the AOAC (Association of Analytical Communities) annual meeting in Las Vegas next week and will be available as technical notes, the first of which can be viewed at www.phenomenex.com/cdpr.
The FDA has increased its scrutiny of the supplement industry in recent years, precipitating a need for faster, more advanced quality control methods. "The ability to provide a complete package of reference standards and scientifically valid methods strengthens our leadership position and provides a 'one-stop shop' for our customers," said Frank Jaksch, CEO and founder of ChromaDex. "The collaboration will deliver tools to help customers meet FDA guidance on cGMP (current good manufacturing practices) for dietary supplements."
Phenomenex maintains a full-service analytical support laboratory, staffed with application scientists who specialize in method development and customized solutions. This team will optimize methods for ChromaDex reference standards, based on the most advanced chromatography technology. This includes working with a variety of sample matrices and will in many cases include the use of Phenomenex's core-shell particle technology and Kinetex ® columns.
"This collaboration is consistent with our strategy of providing the most complete solutions to the customers we serve," explains Sky Countryman, manager of PhenoLogix and applied technology for Phenomenex. "We look forward to expanding our involvement with the growing dietary supplement market."About ChromaDex:
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV